FORA
Forian Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$2.17
+0.00%Year over year
Reported trailing growth
- Revenue
- +34.6%
- EBITDA
- -37.0%
- EBIT
- +39.2%
- EPS
- -40.3%
- Free cash flow
- -20.7%
- Operating cash flow
- -35.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +22.6%
- EBITDA
- +23.1%
- EBIT
- +64.7%
- Net income
- +23.8%
- EPS
- +23.0%
- Free cash flow
- +110.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026